Study suggests that toddlers first treated with recombinant factor product are more likely to develop an inhibitor.
- Read more about SIPPET Results to be Presented at ASH 2015
- Log in to post comments
Study suggests that toddlers first treated with recombinant factor product are more likely to develop an inhibitor.